Yuji Koriyama

Shionogi & Co., Ltd.

Title: Discovery and Synthesis of JNJ-54861911, A novel orally active BACE1 inhibitor

---

Biography

Yuji Koriyama is a Director at Head of Frontier & Out-License Group, Business Development at Shionogi & Co., Ltd., Osaka, Japan. Yuji Koriyama completed his Ph.D. in synthetic organic chemistry. 

He has 7.5 yrs in Bayer Yakuin as a medicinal chemist involved in anti-inflammatory, anti-asthma, anti-allergy field, discovering some clinical candidates (IKK-beta inhibitor, CRTH2 antagonist). He also has 7 yrs in Shionogi as a medicinal chemist involved in CNC area including anti-pain and Alzheimer’s disease. During this period, have led a discovery project of beta-secretase (BACE) inhibitor as a project leader, then discovered highly potent orally available inhibitor. He is having 8 yrs in Shionogi business development (3.5 yrs in Licensing team, 3.5 yrs in Alliance management team, 1 yr in Search & evaluation group, 6 months in Frontier & Out-license group as a group head).

Abstract

Medicinal chemistry, Business Development, Alliance Management